Abivax (ABVX) Total Debt (2021 - 2025)

Abivax's Total Debt history runs 5 years deep, the most recent figure standing at $37.4 million for Q4 2025.

• In Q4 2025, Total Debt fell 22.2% year-over-year to $37.4 million; the TTM figure through Dec 2025 stood at $37.4 million (down 22.2% YoY), while the FY2025 annual figure was $37.4 million, down 22.2% from the prior year.
• Total Debt was $37.4 million for Q4 2025 at Abivax, down from $39.2 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $84.4 million in Q2 2025 to a low of $13.0 million in Q4 2021.
• Historically, Total Debt has averaged $47.4 million across 5 years, with a median of $46.5 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Total Debt surged 189.42% in 2022, then decreased 22.2% in 2025.
• A 5-year view of Total Debt shows it stood at $13.0 million in 2021, then soared by 189.42% to $37.6 million in 2022, then rose by 23.76% to $46.5 million in 2023, then climbed by 3.29% to $48.0 million in 2024, then decreased by 22.2% to $37.4 million in 2025.
• The last three Total Debt figures came in at $37.4 million (Q4 2025), $39.2 million (Q3 2025), and $84.4 million (Q2 2025), per Business Quant data.